Background
==========

The heart normally derives most of its energy from the oxidation of fatty acids. Myocardial metabolism can be monitored non-invasively by MRS using hyperpolarized (HP) 13C-labelled compounds; however, the vast majority of studies reported have used HP pyruvate and did not measure fatty acid catabolism. The myocardial metabolism of HP \[1-13C\]butyrate and \[1-13C\]acetate has been reported. The conversion of these short-chain fatty acids to acetyl-CoA does not involve successive rounds of beta-oxidation, as is the case for longer chain fatty acids, which are a more important source of cardiac energy. In this study we examined the applicability of hyperpolarized \[1-13C\]octanoate, a medium-chain fatty acid, as a probe of myocardial metabolism.

Methods
=======

\[1-13C\]octanoic acid (4 M in DMSO, doped with stable trityl radical) was polarized by microwave irradiation (196.8 GHz) at 7 T & 1 K. After dissolution with superheated buffered D2O, \~0.04 mmol was infused via a femoral vein catheter into anesthetized Wistar rats in a 9.4 T horizontal bore scanner (Varian) and a series of single pulse (BIR-4, 300, TR \~3 s) gated 13C MRS acquisitions was performed with a surface coil positioned over the heart. To aid metabolite identification, HP \[1-13C\]acetate and/or 13C-urea were coinfused in several experiments.

Results
=======

After dissolution, \[1-13C\]octanoate polarization level and T1 relaxation rate were \~11% and 29 ± 3 s, respectively. In vivo, the octanoate signal decayed rapidly and was no longer measurable 20-36 s after the start of infusion. Interactions with blood proteins such as serum albumin are likely responsible for the rapid loss of signal, and the T1 in blood ex vivo was \~9.6 ± 0.5 s. One metabolite peak at 175.4 ppm, was consistently observed (Fig [1](#F1){ref-type="fig"}). Summing the FIDs where octanoate was present and integrating the peaks, the metabolite had 1.49 ± 0.20% the area of octanoate C-1 (n=5). The chemical shift of the metabolite was assigned to \[1-13C\]acetylcarnitine. This was confirmed by infusing HP \[1-13C\]acetate and observing \[1-13C\]acetylcarnitine with the same chemical shift, as well as coinfusing HP \[1-13C\]acetate and \[1-13C\]octanoate and observing a single metabolite peak for \[1-13C\]acetylcarnitine.
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Conclusions
===========

This study demonstrates that in-vivo dissolution DNP metabolic experiments can be performed with 13C-labelled medium-chain fatty acids. Sufficient 13C polarization in octanoate survives circulation, tissue uptake, mitochondrial transport and conversion by beta-oxidation to acetyl-CoA to be detectible in the acetylcarnitine pool. HP octanoate can be used to directly probe the beta-oxidation of metabolically important fatty acids in the heart.
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